
Lifeloc Technologies, Inc
93
Recent news includes insider share purchases and financing secured for growth, with no major operational announcements.
- The Chief Financial Officer purchased 12,250 shares in April 2025, indicating insider confidence [N8].
- Lifeloc Technologies secured financing aimed at supporting innovative growth initiatives as of March 2026 [N8].
Lifeloc Technologies, Inc operates with a business model that includes product sales to a concentrated customer base, with significant reliance on a few customers without long-term contracts. The company maintains liquidity and invests in growth but has reported a net loss in the latest quarter. It faces operational risks from economic conditions, trade policies, and geopolitical instability. The company also manages cybersecurity risks primarily through third-party providers. Its stock trades on OTC markets with limited liquidity and significant ownership concentration.
Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice. Lifeloc Technologies, Inc reported $2.52 million in revenue and a net loss of $84,931 for the quarter ended September 30, 2026. The company maintains strong liquidity with a current ratio of 3.95 and cash ratio of 1.96 as of the same date. Risks include customer concentration, reliance on key personnel, cybersecurity, and geopolitical and economic uncertainties [S2][S1].
Lifeloc Technologies has maintained liquidity and secured financing for growth initiatives. Insider purchases indicate confidence from management. The company’s ability to manage cybersecurity risks and maintain customer relationships could support operational stability.
Risks include revenue concentration from a few customers without long-term contracts, dependence on key executives, potential impacts from geopolitical and economic instability, and limited stock liquidity. The company has reported net losses and faces challenges in attracting and retaining skilled employees.
The company’s moat is not explicitly detailed in the available disclosures. However, reliance on key personnel and specialized products suggests some operational uniqueness. The significant ownership concentration may influence strategic decisions but also poses governance risks.
• Customer Concentration Risk: A significant portion of revenues comes from three customers without long-term contracts, which could adversely affect revenues if lost [S1].
• Key Personnel Dependence: The company’s success heavily depends on its CEO, whose loss could severely damage the business [S1].
• Economic and Geopolitical Risks: Global economic conditions, trade policies, tariffs, and geopolitical conflicts may disrupt operations and supply chains [S1].
• Cybersecurity Risks: The company relies on third-party providers for cybersecurity management and faces risks from potential cyber incidents [S1].
• Stock Liquidity and Ownership Concentration: Shares trade on OTC markets with low liquidity and high volatility; a principal stockholder owns approximately 77% of shares, affecting governance [S1].
Business trends: The company operates in a challenging environment with concentrated customers and ongoing economic and geopolitical uncertainties.
Execution milestones: Maintaining liquidity, managing cybersecurity risks, and securing financing for growth are key operational focuses.
Key risks: Customer dependency, CEO reliance, cybersecurity vulnerabilities, and limited stock market liquidity remain significant concerns.
Very high visibility
Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).
- Lifeloc Technologies, Inc is a company with publicly available SEC filings including a 10-K filed on 2026-03-27 and a 10-Q filed on 2026-11-13 [S1][S2].
- As of September 30, 2026, the company reported cash and cash equivalents of $2,251,315 and current assets of $4,546,143, with current liabilities of $1,150,471, resulting in a current ratio of 3.95 and a cash ratio of 1.96 [S2].
- For the quarter ended September 30, 2026, Lifeloc Technologies reported revenues of $2,521,874 and a net loss of $84,931, with basic and diluted EPS of -$0.03 per share [S2].
- The company faces risks from global economic conditions, including fluctuations in exchange rates, trade policies, tariffs, and geopolitical instability that may affect operations, supply chain, and financial performance [S1].
- Lifeloc Technologies relies on a small number of customers for a significant portion of its revenues, with 18% of product sales in 2025 attributable to three customers without long-term contracts, posing revenue concentration risk [S1].
- The company depends heavily on its Chief Executive Officer, Dr. Wayne R. Willkomm, whose loss could severely damage the business [S1].
- Labor shortages and the ability to attract and retain employees with scientific and technical skills are noted as operational risks [S1].
- The company is subject to cybersecurity risks and relies on third-party providers for cybersecurity risk management; to date, no material cybersecurity incidents have affected the business [S1].
- Shares of the company's common stock lack a significant trading market and are not listed on a national securities exchange, trading instead on OTC markets which are highly illiquid and volatile [S1].
- The principal stockholder, Vern D. Kornelsen, beneficially owns approximately 77% of the outstanding common stock, giving him significant control over corporate decisions [S1].
- The company has never declared or paid cash dividends and intends to retain earnings to support operations and expansion [S1].
- Recent news coverage includes an insider purchase by the Chief Financial Officer of 12,250 shares reported in April 2025 and a report of the company securing financing for innovative growth as of March 2026 [N8].
Generated 2026-11-14
- S1 | 2026-03-27 | 10-K
- S2 | 2026-11-13 | 10-Q
- N1 | 2026-11-14 | www.nasdaq.com | CoreWeave Stock Surges as Revenue Soars. Is It Too Late to Buy the Stock? | https://www.nasdaq.com/articles/coreweave-stock-surges-revenue-soars-it-too-late-buy-stock
- N2 | 2026-11-14 | www.nasdaq.com | Warren Buffett Said This 1 Mistake Cost Berkshire About $10 Billion. Here’s How Investors Can Avoid It. | https://www.nasdaq.com/articles/warren-buffett-said-1-mistake-cost-berkshire-about-10-billion-heres-how-investors-can
- N3 | 2026-11-14 | www.nasdaq.com | Could Oracle Hit Its $30 Billion Free Cash Flow Target by Fiscal 2029? | https://www.nasdaq.com/articles/could-oracle-hit-its-30-billion-free-cash-flow-target-fiscal-2029
- N4 | 2026-11-14 | www.nasdaq.com | Billionaire Bill Ackman Says There’s a Huge Disconnect in Wall Street’s Expectations for Amazon, Microsoft, Meta, and Alphabet | https://www.nasdaq.com/articles/billionaire-bill-ackman-says-theres-huge-disconnect-wall-streets-expectations-amazon
- N5 | 2026-11-14 | www.nasdaq.com | Prediction: This Will Be CoreWeave’s Stock Price After 1 Year Following Its Stunning Results (Hint: It Implies a Big Move) | https://www.nasdaq.com/articles/prediction-will-be-coreweaves-stock-price-after-1-year-following-its-stunning-results-hint
- N6 | 2026-08-17 | www.nasdaq.com | Alphabet's Reported $112 Billion Profit Included a $94 Billion Paper Gain From SpaceX. Here's What the Company Actually Earned. | https://www.nasdaq.com/articles/alphabets-reported-112-billion-profit-included-94-billion-paper-gain-spacex-heres-what
- N7 | 2026-08-17 | www.nasdaq.com | Argenx Reports Positive Phase 3 Results In Autoimmune Myositis; Stock Up | https://www.nasdaq.com/articles/argenx-reports-positive-phase-3-results-autoimmune-myositis-stock
- N8 | 2026-08-17 | www.nasdaq.com | 3 Nuclear Stocks With Real Revenue vs. 3 That Are Still Pre-Revenue. Here's Where the Money Actually Is. | https://www.nasdaq.com/articles/3-nuclear-stocks-real-revenue-vs-3-are-still-pre-revenue-heres-where-money-actually
This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Generated by Valye SEC Pipeline Engine
.gif)


